(CHWY) Chewy - NYSE
Sector: Consumer Cyclical | Industry: Internet Retail | Exchange: NYSE (USA) | Market Cap: 7.918m USD | Total Return: -54.7% in 12m
Avg Turnover: 203M
EPS Trend: 94.0%
Qual. Beats: 1
Rev. Trend: 98.8%
Qual. Beats: -1
Warnings
Altman Z'' -1.64 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Chewy, Inc. is a leading e-commerce retailer specializing in pet food, supplies, and healthcare products within the United States. The company operates through a digital-first model, utilizing its proprietary websites and mobile applications to distribute a wide range of pet-related goods and professional services.
A core component of the business model is the Autoship subscription program, which generates recurring revenue by automating the delivery of essential pet consumables. This reflects a broader trend in the specialty retail sector where high-frequency, low-volatility purchases are increasingly shifting from brick-and-mortar locations to direct-to-consumer platforms.
The company expanded its addressable market by integrating pet health services and medications into its ecosystem, leveraging the high consumer loyalty inherent in the pet care industry. For a deeper look into the companys fundamentals, you may find it useful to explore more data on ValueRay.
- Autoship subscription program growth drives predictable recurring revenue and customer retention
- Expansion of high-margin pet health services and pharmacy offerings improves profitability
- Active customer base stabilization and growth trends dictate long-term market valuation
- Logistics and fulfillment efficiency gains reduce shipping costs to expand operating margins
- Discretionary consumer spending levels impact premium pet food and hard goods sales volume
| Net Income: 199.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 3.04 > 1.0 |
| NWC/Revenue: -3.97% < 20% (prev -3.54%; Δ -0.43% < -1%) |
| CFO/TA 0.22 > 3% & CFO 713.7m > Net Income 199.6m |
| Net Debt (-36.0m) to EBITDA (356.2m): -0.10 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (424.1m) vs 12m ago -0.28% < -2% |
| Gross Margin: 29.72% > 18% (prev 29.24%; Δ 0.49% > 0.5%) |
| Asset Turnover: 400.7% > 50% (prev 395.4%; Δ 5.32% > 0%) |
| Interest Coverage Ratio: 47.80 > 6 (EBIT TTM 219.9m / Interest Expense TTM 4.60m) |
| A: -0.15 (Total Current Assets 1.84b - Total Current Liabilities 2.34b) / Total Assets 3.30b |
| B: -0.38 (Retained Earnings -1.27b / Total Assets 3.30b) |
| C: 0.07 (EBIT TTM 219.9m / Avg Total Assets 3.18b) |
| D: 0.15 (Book Value of Equity 424.2m / Total Liabilities 2.88b) |
| Altman-Z'' = -1.64 = D |
| DSRI: 1.10 (Receivables 231.4m/200.0m, Revenue 12.8b/12.1b) |
| GMI: 0.98 (GM 29.24% / 29.72%) |
| AQI: 1.29 (AQ_t 0.14 / AQ_t-1 0.11) |
| SGI: 1.05 (Revenue 12.8b / 12.1b) |
| TATA: -0.16 (NI 199.6m - CFO 713.7m) / TA 3.30b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of June 17, 2026, the stock is trading at USD 18.87 with a total of 9,149,499 shares traded.
Over the past week, the price has changed by -7.50%,
over one month by -12.76%,
over three months by -24.88% and
over the past year by -54.70%.
Chewy has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy CHWY.
- StrongBuy: 11
- Buy: 6
- Hold: 12
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 31.2 | 65.6% |
P/E Trailing = 32.2333
P/E Forward = 13.3869
P/S = 0.6166
P/B = 18.6663
P/EG = 0.3503
Revenue TTM = 12.8b USD
EBIT TTM = 219.9m USD
EBITDA TTM = 356.2m USD
Long Term Debt = unknown (none)
Short Term Debt = 38.1m USD (from shortTermDebt, last fiscal year)
Debt = 484.1m USD (from shortLongTermDebtTotal, last quarter) (leases 484.1m already included)
Net Debt = -36.0m USD (calculated: Debt 484.1m - CCE 520.1m)
Enterprise Value = 7.88b USD (7.92b + Debt 484.1m - CCE 520.1m)
Interest Coverage Ratio = 47.80 (Ebit TTM 219.9m / Interest Expense TTM 4.60m)
EV/FCF = 13.49x (Enterprise Value 7.88b / FCF TTM 584.5m)
FCF Yield = 7.42% (FCF TTM 584.5m / Enterprise Value 7.88b)
FCF Margin = 4.58% (FCF TTM 584.5m / Revenue TTM 12.8b)
Net Margin = 1.57% (Net Income TTM 199.6m / Revenue TTM 12.8b)
Gross Margin = 29.72% ((Revenue TTM 12.8b - Cost of Revenue TTM 8.96b) / Revenue TTM)
Gross Margin QoQ = 29.40% (prev 29.40%)
Tobins Q-Ratio = 2.39 (Enterprise Value 7.88b / Total Assets 3.30b)
Interest Expense / Debt = 0.95% (Interest Expense 4.60m / Debt 484.1m)
Taxrate = 12.26% (27.9m / 227.5m)
NOPAT = 192.9m (EBIT 219.9m * (1 - 12.26%))
Current Ratio = 0.78 (Total Current Assets 1.84b / Total Current Liabilities 2.34b)
Debt / Equity = 1.14 (Debt 484.1m / totalStockholderEquity, last quarter 424.2m)
Debt / EBITDA = -0.10 (Net Debt -36.0m / EBITDA 356.2m)
Debt / FCF = -0.06 (Net Debt -36.0m / FCF TTM 584.5m)
Total Stockholder Equity = 445.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.27% (Net Income 199.6m / Total Assets 3.30b)
RoE = 44.82% (Net Income TTM 199.6m / Total Stockholder Equity 445.4m)
RoCE = 22.93% (EBIT 219.9m / Capital Employed (Total Assets 3.30b - Current Liab 2.34b))
RoIC = 40.43% (NOPAT 192.9m / Invested Capital 477.2m)
WACC = 8.41% (E(7.92b)/V(8.40b) * Re(8.87%) + D(484.1m)/V(8.40b) * Rd(0.95%) * (1-Tc(0.12)))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -67.42 | Cagr: -1.01%
[DCF] Terminal Value 77.79% ; FCFF base≈530.1m ; Y1≈607.7m ; Y5≈894.4m
[DCF] Fair Price = 57.36 (EV 13.3b - Net Debt -36.0m = Equity 13.4b / Shares 232.9m; r=8.41% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.96 | EPS CAGR: 51.70% | SUE: 1.77 | # QB: 1
Revenue Correlation: 98.78 | Revenue CAGR: 6.55% | SUE: -4.0 | # QB: -1
EPS current Quarter (2026-07-31): EPS=0.43 | Chg30d=N/A | Revisions=-50% | Analysts=16
EPS next Quarter (2026-10-31): EPS=0.38 | Chg30d=-6.76% | Revisions=-20% | Analysts=14
EPS current Year (2027-01-31): EPS=1.52 | Chg30d=-5.77% | Revisions=-60% | GrowthEPS=+20.1% | GrowthRev=+7.1%
EPS next Year (2028-01-31): EPS=1.84 | Chg30d=-6.25% | Revisions=-40% | GrowthEPS=+20.9% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: -60%